BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11470294)

  • 1. In vivo and in vitro lipidation of recombinant immunogens for direct iscom incorporation.
    Andersson C; Wikman M; Lövgren-Bengtsson K; Lundén A; Ståhl S
    J Immunol Methods; 2001 Sep; 255(1-2):135-48. PubMed ID: 11470294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applying biotin-streptavidin binding for iscom (immunostimulating complex) association of recombinant immunogens.
    Wikman M; Friedman M; Pinitkiatisakul S; Hemphill A; Lövgren-Bengtsson K; Lundén A; Ståhl S
    Biotechnol Appl Biochem; 2005 Apr; 41(Pt 2):163-74. PubMed ID: 15296488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved systems for hydrophobic tagging of recombinant immunogens for efficient iscom incorporation.
    Andersson C; Sandberg L; Wernérus H; Johansson M; Lövgren-Bengtsson K; Ståhl S
    J Immunol Methods; 2000 Apr; 238(1-2):181-93. PubMed ID: 10758248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General expression vectors for production of hydrophobically tagged immunogens for direct iscom incorporation.
    Andersson C; Sandberg L; Murby M; Sjölander A; Lövgren-Bengtsson K; Ståhl S
    J Immunol Methods; 1999 Jan; 222(1-2):171-82. PubMed ID: 10022383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General strategies for efficient adjuvant incorporation of recombinant subunit immunogens.
    Wikman M; Friedman M; Pinitkiatisakul S; Andersson C; Hemphill A; Lövgren-Bengtsson K; Lundén A; Ståhl S
    Vaccine; 2005 Mar; 23(17-18):2331-5. PubMed ID: 15755622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and protective effect against murine cerebral neosporosis of recombinant NcSRS2 in different iscom formulations.
    Pinitkiatisakul S; Friedman M; Wikman M; Mattsson JG; Lövgren-Bengtsson K; Ståhl S; Lundén A
    Vaccine; 2007 May; 25(18):3658-68. PubMed ID: 17280751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of iscom antigen preparations in ELISAs for diagnosis of Neospora and Toxoplasma infections.
    Björkman C; Lundén A
    Int J Parasitol; 1998 Jan; 28(1):187-93. PubMed ID: 9504345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of immune responses to experimental polyvalent subunit vaccines assembled in iscoms.
    Sjölander A; Ahlborg N; Ståhl S; Andersson R
    Mol Immunol; 1998 Feb; 35(3):159-66. PubMed ID: 9694516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide.
    Sánchez-López EF; Corigliano MG; Albarracín RM; Sander VA; Legarralde A; Bengoa-Luoni SA; Clemente M
    Parasit Vectors; 2019 Mar; 12(1):140. PubMed ID: 30909938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of toxoplasma gondii induces immune response and protection against infection in mice.
    Caetano BC; Bruña-Romero O; Fux B; Mendes EA; Penido ML; Gazzinelli RT
    Hum Gene Ther; 2006 Apr; 17(4):415-26. PubMed ID: 16610929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
    Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant attenuated Toxoplasma gondii expressing the Plasmodium yoelii circumsporozoite protein provides highly effective priming for CD8+ T cell-dependent protective immunity against malaria.
    Charest H; Sedegah M; Yap GS; Gazzinelli RT; Caspar P; Hoffman SL; Sher A
    J Immunol; 2000 Aug; 165(4):2084-92. PubMed ID: 10925293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
    Zheng B; Lu S; Tong Q; Kong Q; Lou D
    Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and characterization of a recombinant colorimetric SAG1-alkaline phosphatase conjugate to detect specific antibody responses against Toxoplasma gondii.
    Chahed Bel-Ochi N; Bouratbine A; Mousli M
    J Immunol Methods; 2013 Aug; 394(1-2):107-14. PubMed ID: 23727049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV experimental vaccines based on the iscom technology using envelope and GAG gene products.
    Akerblom L; Nara P; Dunlop N; Putney S; Morein B
    Biotechnol Ther; 1993; 4(3-4):145-61. PubMed ID: 8292967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model.
    Fang R; Feng H; Nie H; Wang L; Tu P; Song Q; Zhou Y; Zhao J
    Vaccine; 2010 Feb; 28(7):1803-7. PubMed ID: 20018269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified protection against Toxoplasma gondii lethal infection and brain cyst formation by vaccination with SAG2 and SRS1.
    Mishima M; Xuan X; Shioda A; Omata Y; Fujisaki K; Nagasawa H; Mikami T
    J Vet Med Sci; 2001 Apr; 63(4):433-8. PubMed ID: 11346179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological response of sheep to injections of plasmids encoding Toxoplasma gondii SAG1 and ROP1 genes.
    Li B; Oledzka G; McFarlane RG; Spellerberg MB; Smith SM; Gelder FB; Kur J; Stankiewicz M
    Parasite Immunol; 2010; 32(9-10):671-83. PubMed ID: 20691019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fusion of Toxoplasma gondii SAG1 vaccine candidate to Leishmania infantum heat shock protein 83-kDa improves expression levels in tobacco chloroplasts.
    Albarracín RM; Becher ML; Farran I; Sander VA; Corigliano MG; Yácono ML; Pariani S; López ES; Veramendi J; Clemente M
    Biotechnol J; 2015 May; 10(5):748-59. PubMed ID: 25823559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice.
    Golkar M; Shokrgozar MA; Rafati S; Musset K; Assmar M; Sadaie R; Cesbron-Delauw MF; Mercier C
    Vaccine; 2007 May; 25(21):4301-11. PubMed ID: 17418457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.